NASDAQ: CGC · Life Sciences · 6 alerts · CIK 1737927
Share price
$0.5460Close, Nov 16
Market cap
$231M
Shares outstanding
423.35MLatest SEC cover page
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Canopy Growth Corp filings on SEC EDGAR ↗
Canopy Growth reported Q2 FY2027 consolidated net revenue of $81.4M, a 22% year-over-year increase driven by 141% growth in international markets. The company saw strong performance in its cannabis segment, particularly in Germany and Poland, and is targeting positive adjusted EBITDA during fiscal 2027.
Term
Q2 2027
“We have made tremendous progress on our international strategy. Our international business delivered 141% net revenue growth in the second quarter of fiscal year 2027 driven by strong medical cannabis sales in Germany and Poland.”
Luc Mongeau, Chief Executive Officer
“We reported another quarter of strong net revenue growth, including a 17% year-over-year increase in Canada adult-use cannabis, an 18% increase in Canada medical cannabis and 30% growth in the Cannabis segment overall. We are progressing steadily to profitability, quarter after quarter.”
Canopy Growth reported a net revenue of $81.4 million for the quarter ended September 30, 2026, a 22% increase compared to the prior year. Despite the revenue growth, the company recorded a net loss of $40.7 million for the quarter, driven by increased operating expenses and a $23.0 million operating loss.
Canopy Growth shareholders approved a special resolution at the 2026 Annual General and Special Meeting to authorize a reverse stock split. The Board has the discretion to consolidate common and exchangeable shares at a ratio between 1-for-5 and 1-for-15 at any time prior to September 25, 2027.
Canopy Growth Corporation received a deficiency notice from Nasdaq on October 14, 2026, because its common shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Canopy Growth is currently seeking shareholder approval for a potential reverse stock split at its upcoming annual meeting to address the deficiency.
Canopy Growth Insider Theresa Yanofsky Sells $13.8K of Stock
Theresa Yanofsky sold 14,920 shares of Canopy Growth Corp at $0.9268 a share, worth $13.8K in total on Sep 28, 2026. Shares held after the trade: 131,495 (-10.2%).
Canopy Growth Insider David Angelo Lazzarato Sells $20.7K of Stock
David Angelo Lazzarato sold 22,380 shares of Canopy Growth Corp at $0.9268 a share, worth $20.7K in total on Sep 28, 2026. Shares held after the trade: 189,479 (-10.6%).